Robert Wong - 14 Mar 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
VP, Chief Accounting Officer
Signature
/s/ John Faurescu, attorney-in-fact for Mr. Wong
Issuer symbol
CYTK
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
4
Filing time
18 Mar 2024, 19:07:33 UTC
Previous filing
07 Mar 2024
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +4,079 +16% $0.000000 29,664 14 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (Right to Buy) Award $0 +1,403 $0.000000 1,403 14 Mar 2024 Common Stock 1,403 $63.75 Direct F2
transaction CYTK Non-Qualified Stock Option (Right to Buy) Award $0 +3,308 $0.000000 3,308 14 Mar 2024 Common Stock 3,308 $63.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.
F2 This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028.